Daniel Adunkwah: Reimagining Safety and Choice with Autologous Blood Transfusions
Daniel Adunkwah, Doctor of Medical Laboratory Science, Laboratory Manager at Presbyterian Health Services, shared a post on LinkedIn:
“Autologous Blood Transfusion: A Significant Moment in Patient Care and Choice
Recent developments within the community of Jehovah’s Witnesses have brought renewed attention to an important medical practice, autologous blood transfusion. With increasing openness toward members receiving their own blood, this approach is becoming even more relevant in clinical care and patient centered medicine.
Autologous blood transfusion involves collecting and reinfusing a patient’s own blood, either before surgery or during a medical procedure. It is a concept that continues to bridge medical innovation with individual beliefs and healthcare preferences.
1. Why this matters now
Autologous transfusion provides an option that aligns medical treatment with personal convictions. For many patients, especially those who have previously declined donor blood, this development offers a pathway to safer surgical care while respecting deeply held beliefs.
2. Clinical significance
From a clinical perspective, autologous blood transfusion reduces the risk of transfusion transmitted infections and eliminates compatibility concerns. It is particularly useful in surgeries where significant blood loss is expected, and it supports modern strategies in patient blood management.
3. The broader healthcare insight
This moment highlights something important in medicine, the need to continually adapt care to meet patients where they are. When clinical science and patient values work together, outcomes improve and trust in healthcare grows stronger.
Autologous blood transfusion reminds us that sometimes the safest and most acceptable solution is one that comes directly from the patient themselves.
Dr. Daniel Adunkwah
Doctor of Medical Laboratory Science”
Stay updated with Hemostasis Today.
-
Mar 24, 2026, 16:44Robert Talac: Is PRP Truly Autologous?
-
Mar 24, 2026, 16:42Peter Jaworski: The Shift in Plasma Center Locations Is About Demand, Not Economics
-
Mar 24, 2026, 16:41Apolipoprotein C3 as A Paradoxical Inhibitor of Platelet Aggregation and Thrombosis – JTH
-
Mar 24, 2026, 16:38Chris Centeno: Can Platelet Concentration Be Back-Calculated from Blood Draw Volume as a Surrogate?
-
Mar 24, 2026, 16:33Gaetan Duport: The Next Challenge for Patient Involvement at EMA
-
Mar 24, 2026, 16:27ABL Tyrosine Kinase Inhibitors Linked to Arterial Thrombosis – Blood Journals Portfolio
-
Mar 24, 2026, 16:21Wolfgang Miesbach: Infections as a Trigger for Stroke in Young Adults
-
Mar 24, 2026, 16:19Sue Hill: How a Biomedical Scientist’s Curiosity is Improving Patient Care
-
Mar 24, 2026, 16:16Seema Dawood: Platelet Satellitism – An EDTA-Dependent Cause of Pseudothrombocytopenia